Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Multiomics Market, by Type
1.4.2 Europe Multiomics Market, by Product & Service
1.4.3 Europe Multiomics Market, by End-use
1.4.4 Europe Multiomics Market, by Platform
1.4.5 Europe Multiomics Market, by Application
1.4.6 Europe Multiomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jun – 2023, Mar) Leading Players
4.4 Porter’s Five Force Analysis
Chapter 5. Europe Multiomics Market by Type
5.1 Europe Bulk Multiomics Market by Country
5.2 Europe Single-cell Multiomics Market by Country
Chapter 6. Europe Multiomics Market by Product & Service
6.1 Europe Product Market by Country
6.2 Europe Multiomics Market by Product Type
6.2.1 Europe Instruments Market by Country
6.2.2 Europe Consumables Market by Country
6.2.3 Europe Software Market by Country
6.3 Europe Services Market by Country
Chapter 7. Europe Multiomics Market by End-use
7.1 Europe Academic & Research Institutes Market by Country
7.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
7.3 Europe Others Market by Country
Chapter 8. Europe Multiomics Market by Platform
8.1 Europe Genomics Market by Country
8.2 Europe Transcriptomics Market by Country
8.3 Europe Proteomics Market by Country
8.4 Europe Metabolomics Market by Country
8.5 Europe Integrated Omics Platforms Market by Country
Chapter 9. Europe Multiomics Market by Application
9.1 Europe Cell Biology Market by Country
9.2 Europe Oncology Market by Country
9.3 Europe Neurology Market by Country
9.4 Europe Immunology Market by Country
Chapter 10. Europe Multiomics Market by Country
10.1 Germany Multiomics Market
10.1.1 Germany Multiomics Market by Type
10.1.2 Germany Multiomics Market by Product & Service
10.1.2.1 Germany Multiomics Market by Product Type
10.1.3 Germany Multiomics Market by End-use
10.1.4 Germany Multiomics Market by Platform
10.1.5 Germany Multiomics Market by Application
10.2 UK Multiomics Market
10.2.1 UK Multiomics Market by Type
10.2.2 UK Multiomics Market by Product & Service
10.2.2.1 UK Multiomics Market by Product Type
10.2.3 UK Multiomics Market by End-use
10.2.4 UK Multiomics Market by Platform
10.2.5 UK Multiomics Market by Application
10.3 France Multiomics Market
10.3.1 France Multiomics Market by Type
10.3.2 France Multiomics Market by Product & Service
10.3.2.1 France Multiomics Market by Product Type
10.3.3 France Multiomics Market by End-use
10.3.4 France Multiomics Market by Platform
10.3.5 France Multiomics Market by Application
10.4 Russia Multiomics Market
10.4.1 Russia Multiomics Market by Type
10.4.2 Russia Multiomics Market by Product & Service
10.4.2.1 Russia Multiomics Market by Product Type
10.4.3 Russia Multiomics Market by End-use
10.4.4 Russia Multiomics Market by Platform
10.4.5 Russia Multiomics Market by Application
10.5 Spain Multiomics Market
10.5.1 Spain Multiomics Market by Type
10.5.2 Spain Multiomics Market by Product & Service
10.5.2.1 Spain Multiomics Market by Product Type
10.5.3 Spain Multiomics Market by End-use
10.5.4 Spain Multiomics Market by Platform
10.5.5 Spain Multiomics Market by Application
10.6 Italy Multiomics Market
10.6.1 Italy Multiomics Market by Type
10.6.2 Italy Multiomics Market by Product & Service
10.6.2.1 Italy Multiomics Market by Product Type
10.6.3 Italy Multiomics Market by End-use
10.6.4 Italy Multiomics Market by Platform
10.6.5 Italy Multiomics Market by Application
10.7 Rest of Europe Multiomics Market
10.7.1 Rest of Europe Multiomics Market by Type
10.7.2 Rest of Europe Multiomics Market by Product & Service
10.7.2.1 Rest of Europe Multiomics Market by Product Type
10.7.3 Rest of Europe Multiomics Market by End-use
10.7.4 Rest of Europe Multiomics Market by Platform
10.7.5 Rest of Europe Multiomics Market by Application
Chapter 11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Illumina, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.2.5.3 Acquisition and Mergers:
11.2.5.4 Geographical Expansions:
11.2.6 SWOT Analysis
11.3 Danaher Corporation
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 SWOT Analysis
11.4 PerkinElmer, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bruker Corporation
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Qiagen N.V.
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Agilent Technologies, Inc.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Partnerships, Collaborations, and Agreements:
11.7.6 SWOT Analysis
11.8 BGI Group
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.3 SWOT Analysis
11.9 Becton, Dickinson, and Company
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.4.1 Product Launches and Product Expansions:
11.9.5 SWOT Analysis
11.10. Shimadzu Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis
Unique Offerings 